Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01261546Phase 2Completed
Phase 2, randomised, double-blind trial in parapneumonic pleural effusion and empyema comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Time to resolution of parapneumonic pleural effusion at 1 month. Started Dec 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01261546.